High risk of breast cancer associated with genetic variation in leptin and it...( Individuals with either of two genetic ...),Health

Individuals with either of two genetic variations that lead to high serum levels of the cytokine leptin and to overexpression of leptin in fatty tissue, are more at risk of developing breast cancer than others. A study published today in the open access journal BMC Cancer suggests that individuals with a specific genetic variation (polymorphism) in the gene LEP that encodes for leptin, or a polymorphism in the gene LEPR, encoding for its receptor, have an increased risk of breast cancer. This contradicts previous results that showed no link between the polymorphism in LEPR and the risk of breast cancer. Both polymorphisms could be used as markers to identify people at risk of breast cancer. As they are both associated with a shorter survival time they could potentially serve as predictors of prognosis.

Kaouther Snoussi, from the Universit de Monastir, Monastir, Tunisia and colleagues from other institutions in Tunisia and Scripps-Florida, USA, matched 308 patients diagnosed with breast carcinoma with 222 healthy individuals who had no personal or family history of cancer and acted as controls. The authors genotyped both patients and control individuals for a specific polymorphism in either LEP or LEPR.

Snoussi et al.'s results show that individuals with the LEP polymorphism had a higher risk of developing breast cancer than individuals who do not have it. The risk increased for individuals with two copies of the polymorphism (homozygote) and these people had a threefold higher risk of developing breast cancer than individuals who do not have the polymorphism at all. The frequency of individuals with the LEPR polymorphism was significantly higher in the group of patients than in the group of controls. The LEP polymorphism was also associated with a large tumour size at diagnosis and decreased disease-free survival, while the LEPR polymorphism was associated with a shorter overall survival time.

'"/>

Contact: Juliette Savin
juliette.savin@biomedcentral.com
44-207-631-9931
BioMed Central
19-Feb-2006

Page: 1
Related medicine news :

1. Survival differences by race most apparent in advanced stages of breast cancer
2. Regulator of lipid metabolism ensures high quality breast milk
3. MRI finds breast cancer before it becomes dangerous
4. New cause of tamoxifen resistance in breast cancer cells discovered at Lombardi
5. Pathway links inflammation, angiogenesis and breast cancer
6. Using MRI for diagnosis could help prevent breast cancer progression
7. Speeding up CT scans with cellphone technology, ultrasound warning signal for breast cancer
8. Fluorescence diffuse optical tomography provides high contrast, 3-D look at breast cancer
9. Dartmouths alternative breast imaging techniques sort abnormal from normal tissue
10. Benefits of trastuzumab are lasting, reducing both HER2 + breast cancer deaths and recurrence
11. Hot flashes may be welcome sign in women with breast cancer, study says